NCCN Guidelines® Insights: Lung cancer screening, version 1.2022: Featured updates to the NCCN Guidelines Guidelines


Authors: Wood, D. E.; Kazerooni, E. A.; Aberle, D.; Berman, A.; Brown, L. M.; Eapen, G. A.; Ettinger, D. S.; Ferguson, J. S.; Hou, L.; Kadaria, D.; Klippenstein, D.; Kumar, R.; Lackner, R. P.; Leard, L. E.; Lennes, I. T.; Leung, A. N. C.; Mazzone, P.; Merritt, R. E.; Midthun, D. E.; Onaitis, M.; Pipavath, S.; Pratt, C.; Puri, V.; Raz, D.; Reddy, C.; Reid, M. E.; Sandler, K. L.; Sands, J.; Schabath, M. B.; Studts, J. L.; Tanoue, L.; Tong, B. C.; Travis, W. D.; Wei, B.; Westover, K.; Yang, S. C.; McCullough, B.; Hughes, M.
Title: NCCN Guidelines® Insights: Lung cancer screening, version 1.2022: Featured updates to the NCCN Guidelines
Abstract: The NCCN Guidelines for Lung Cancer Screening recommend criteria for selecting individuals for screening and provide recommendations for evaluation and follow-up of lung nodules found during initial and subsequent screening. These NCCN Guidelines Insights focus on recent updates to the NCCN Guidelines for Lung Cancer Screening.
Keywords: lung neoplasms; mass screening; lung tumor; early detection of cancer; humans; human; early cancer diagnosis
Journal Title: Journal of the National Comprehensive Cancer Network
Volume: 20
Issue: 7
ISSN: 1540-1405
Publisher: Harborside Press  
Date Published: 2022-07-01
Start Page: 754
End Page: 764
Language: English
DOI: 10.6004/jnccn.2022.0036
PUBMED: 35830884
PROVIDER: scopus
DOI/URL:
Notes: Article -- Export Date: 1 August 2022 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. William D Travis
    743 Travis